Eli Lilly and Co (USD)
LLY
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range151.58 | 153.50
52-Wk Range- | -
Last Close152.93
Mkt Cap (m)146,273.01
Dividend yield1.81
ISINUS5324571083
Volume2,017,370.00
Exchange VenueNYS

Company Profile

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Key Information
Price/Earning24.95
Price/Book35.71
Price/Sales6.09
P/CF22.02
Rev Growth (3 year avg)1.69
EPS Growth (3 year avg)0.51
Operating Margin % 24.87
Net Margin %37.27
Return on Equity133.78
Debt/Equity6.06

Documents

Prospectus
en 27/04/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.lilly.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)19,615.6019,958.7021,222.1022,871.3024,555.7022,319.50
Operating Income (m)3,128.503,057.103,841.303,304.904,202.905,549.90
Net Income (m)2,390.502,408.402,737.60-204.103,232.008,318.40
Basic EPS2.232.272.59-0.193.148.93
Avg. Diluted Shares Outstanding (m)1,074.291,065.721,061.831,052.021,033.67935.68
Balance Sheet
USD201420152016201720182019
Current Assets (m)12,179.8012,573.6015,101.4019,202.1020,549.6013,709.60
Non Current Assets (m)24,998.4022,995.3023,704.5025,778.9023,358.8025,576.50
Total Assets (m)37,178.2035,568.9038,805.9044,981.0043,908.4039,286.10
Current Liabilities (m)11,207.508,229.6010,986.6014,535.9011,888.1011,775.20
Total Liabilities (m)------
Total Equity (m)15,373.2014,571.3014,007.7011,592.209,828.702,606.90
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)4,367.102,772.804,851.005,615.605,524.504,836.60
Capital Expenditure (m)-1,565.90-1,626.20-1,092.00-2,163.60-3,018.20-1,353.50
Figures are quoted in USD unless stated otherwise
-
No change
$
152.93
Last Price